Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Abstract. Riociguat is a soluble guanylate cyclase stimulator approved for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). This randomized, double-blind, placebo-controlled study investigated the pharmacokinetics of riociguat and its...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pulm Circ
Egile Nagusiak: Frey, Reiner, Saleh, Soundos, Becker, Corina, Mück, Wolfgang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: University of Chicago Press 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860529/
https://ncbi.nlm.nih.gov/pubmed/27162629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685019
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak